Cargando…

ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIV(mac)251 Challenge

Live-attenuated strains of simian immunodeficiency virus (SIV) routinely confer apparent sterilizing immunity against pathogenic SIV challenge in rhesus macaques. Understanding the mechanisms of protection by live-attenuated SIV may provide important insights into the immune responses needed for pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alpert, Michael D., Harvey, Jackson D., Lauer, W. Anderson, Reeves, R. Keith, Piatak, Michael, Carville, Angela, Mansfield, Keith G., Lifson, Jeffrey D., Li, Wenjun, Desrosiers, Ronald C., Johnson, R. Paul, Evans, David T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426556/ https://www.ncbi.nlm.nih.gov/pubmed/22927823 http://dx.doi.org/10.1371/journal.ppat.1002890

Ejemplares similares

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
por: Jia, Bin, et al.
Publicado: (2009)

SIV Vpx Is Essential for Macrophage Infection but Not for Development of AIDS
por: Westmoreland, Susan V., et al.
Publicado: (2014)

Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection
por: Adnan, Sama, et al.
Publicado: (2016)

Location and Dynamics of the Immunodominant CD8 T Cell Response to SIVΔnef Immunization and SIVmac251 Vaginal Challenge
por: Sasikala-Appukuttan, Arun K., et al.
Publicado: (2013)

Induction of a virus-specific effector–memory CD4(+) T cell response by attenuated SIV infection
por: Gauduin, Marie-Claire, et al.
Publicado: (2006)

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV(mac251) acquisition in macaques
por: Rahman, Mohammad Arif, et al.
Publicado: (2023)

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIV(mac251) Rectal Challenge
por: Tuero, Iskra, et al.
Publicado: (2015)

Engagement of monocytes, NK cells, and CD4(+) Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIV(mac251) vaginal acquisition
por: Gorini, Giacomo, et al.
Publicado: (2020)

Correlates of Protection Against SIV(mac251) Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
por: Tuyishime, Steven, et al.
Publicado: (2018)

Defining HIV and SIV Reservoirs in Lymphoid Tissues
por: Deleage, Claire, et al.
Publicado: (2016)

CD8 T Cell Response Maturation Defined by Anentropic Specificity and Repertoire Depth Correlates with SIVΔnef-induced Protection
por: Adnan, Sama, et al.
Publicado: (2015)

Lv4, an activity that restricts nuclear entry of SIV(MAC)/SIV(SM) in human blood cells
por: Pizzato, Massimo, et al.
Publicado: (2013)

Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
por: Martinez-Navio, José M., et al.
Publicado: (2020)

Innate Lymphoid Cells in HIV/SIV Infections
por: Shah, Spandan V., et al.
Publicado: (2017)

A B cell follicle sanctuary permits persistent productive SIV infection in elite controllers
por: Fukazawa, Yoshinori, et al.
Publicado: (2015)

Immune clearance of highly pathogenic SIV infection
por: Hansen, Scott G., et al.
Publicado: (2013)

Intra-dermal immunisation with SIV gag-based vaccines alone inhibits acquisition of SIVmac251
por: Almond, N, et al.
Publicado: (2012)

Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection
por: Hao, Xing Pei, et al.
Publicado: (2015)

Distinct Phenotype, Longitudinal Changes of Numbers and Cell-Associated Virus in Blood Dendritic Cells in SIV-Infected CD8-Lymphocyte Depleted Macaques
por: Soulas, Caroline, et al.
Publicado: (2015)

Evidence for Env-V2 sieve effect in breakthrough SIV (MAC251) infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs
por: Sina, S, et al.
Publicado: (2012)

A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation
por: Vagenas, Panagiotis, et al.
Publicado: (2010)

Effector-memory T cell responses are associated with protection of rhesus monkeys from mucosal SIV challenge
por: Hansen, Scott G., et al.
Publicado: (2009)

Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine
por: Hansen, Scott G., et al.
Publicado: (2011)

Glycerol monolaurate prevents mucosal SIV transmission
por: Li, Qingsheng, et al.
Publicado: (2009)

Effects of Treatment with Suppressive Combination Antiretroviral Drug Therapy and the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid; (SAHA) on SIV-Infected Chinese Rhesus Macaques
por: Ling, Binhua, et al.
Publicado: (2014)

Predictors of SIV recrudescence following antiretroviral treatment interruption
por: Pinkevych, Mykola, et al.
Publicado: (2019)

GCM-SIV1.5: Optimal Tradeoff between GCM-SIV1 and GCM-SIV2
por: Zhang, Ping
Publicado: (2023)

Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV
por: Marshall, Vickie A., et al.
Publicado: (2018)

Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys
por: Liu, Jinyan, et al.
Publicado: (2008)

CD4 T cell Responses in the CNS during SIV infection
por: Elizaldi, Sonny R, et al.
Publicado: (2023)

Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIV(mac251) infection of rhesus macaques; a pilot study
por: Stevceva, Liljana, et al.
Publicado: (2001)

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251
por: Villefroy, Pascale, et al.
Publicado: (2006)

Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection
por: Li, Haiying, et al.
Publicado: (2013)

Intestinal damage precedes mucosal immune dysfunction in SIV infection
por: Hensley-McBain, Tiffany, et al.
Publicado: (2018)

Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIV(MAC)/SIV(SM)/HIV-2 Lineage Prior to Integration
por: Pizzato, Massimo, et al.
Publicado: (2015)

Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012)

A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products
por: Shin, Young C., et al.
Publicado: (2018)

Impaired RNA incorporation and dimerization in live attenuated leader-variants of SIV(mac239)
por: Whitney, James B, et al.
Publicado: (2006)

Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines
por: Fukazawa, Yoshinori, et al.
Publicado: (2012)

Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys
por: Barouch, Dan H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_onktrlse6m4qutj2m4g64bdaun